Hevea brasiliensis latex allergens: current panel and clinical relevance.
Latex allergy has been studied in detail in Europe and the US over the past two decades, resulting in specific guidelines that succeeded in reducing its incidence in high-risk populations within the medical field. How these developments have affected high-risk populations outside the health care scenario is an important unanswered question. In addition, a second wave of latex allergy may occur in nations that are striving to attain higher economic and technologic standards, including population-dense countries such as China. Therefore, the application of Hevea allergens in novel diagnostic assays and the development of specific latex immunotherapy will provide new opportunities for latex allergy research. In this review, we summarize current knowledge on the immunological properties of the 13 officially accepted Hevea brasiliensis latex allergens.
Wagner
Stefan
S
Center of Physiology and Pathophysiology, Department of Pathophysiology, Medical University of Vienna, Vienna, Austria.
Breiteneder
Heimo
H
D000328:Adult; D000485:Allergens / Q000276:immunology*; D002648:Child; D028482:Hevea / Q000276:immunology*; D006801:Humans; D007159:Immunologic Tests; D020315:Latex Hypersensitivity / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D010940:Plant Proteins / Q000276:immunology*
D000485:Allergens; D010940:Plant Proteins